ELISA and flow cytometry confirmed that NAT10 knockdown significantly increased CCL25 levels, promoting CD8+ T cell recruitment and enhanced cytotoxicity in the tumor microenvironment (Fig. 4g-h). The gene discussed is CD8A; the disease is neoplasm.